Convergence of immunotherapy, radiotherapy and prostate cancer: challenges and opportunities

Immunotherapy. 2017 Aug;9(9):695-699. doi: 10.2217/imt-2017-0059. Epub 2017 Aug 3.

Authors

Michael Green¹, Felix Y Feng², Rohit Mehra³, Daniel E Spratt¹

Affiliations

¹ Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
² Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
³ Department of Pathology, University of Michigan, Ann Arbor, MI, USA.

PMID: 28771102
DOI: 10.2217/imt-2017-0059

No abstract available

Keywords: immunotherapy; prostate cancer; radiotherapy.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Biomarkers, Tumor
Combined Modality Therapy / trends
Humans
Immunotherapy / trends*
Male
Prostatic Neoplasms / therapy*
Radiotherapy / trends*

Substances

Biomarkers, Tumor